Skip main navigation

The elements of a good fungal diagnostic test

In this article, Silke Schelenz describes the elements of a good diagnostic test and some real-life examples of each element.
Elements Of A Good Diagnostic Test
© BSAC

Fungal diagnostics tests

Fungal diagnostic tests may require different attributes in the critical care setting or when managing immunocompromised patients.

Some tests will need to have a high negative predictive value to rule out infection in order to withhold or stop antifungal agents that are being used unnecessarily.

The BDG test

The BDG test, for example, is a quite sensitive test with a high negative predictive value to rule out common fungal infections such as candidiasis in the critical care setting but has only moderate specificity.

For the diagnosis of fungal infection, the BDG is not as specific. It can also be false positive in a patient such as those on certain haemofiltration (membrane compounds can cross-react) or receiving dietary products containing glucan (TPN) etc.

GM

GM is another fungal biomarker used in neutropenic patients to monitor high-risk patients for the development of IPA and twice-weekly screening is commonly recommended for neutropenic haematology patients.

The basic elements of a good fungal diagnostic test

  1. Highly specific in identifying a particular fungal infection, low cross-reactivity with other pathogens or compounds
  2. High sensitivity, meaning the test is almost always 100% positive if a fungal infection is present
  3. A test should also be timely – available with a good turnaround time
  4. Affordability and accessibility
  5. An ideal test should help to monitor treatment success

Unfortunately, most diagnostic tests do not fulfil all these criteria.

A highly sensitive test

A highly sensitive test with moderate specificity (high negative predictive value) can be used to rule out fungal disease but may not be so reliable in detecting a fungal infection (e.g. BDG).

A highly specific test

A highly specific test with moderate sensitivity (high positive predictive value) can be used to assume a fungal disease. A test like this could be used to guide starting or withholding antifungals.

Again, unfortunately, such a test does not exist but instead, a combination of tests (galactomannan together with Aspergillus PCR) is often used to improve the ability to diagnose for example invasive aspergillosis.

Laboratory results are also always interpreted together with the patient’s risk factors (e.g. prolonged neutropenia) and imaging (e.g. high-resolution CT of the chest).

Host factors

Host factors can influence the reliability of a test. As an example, the use of GM in non-neutropenic (ICU) patients may not provide a reliable diagnostic tool for IPA, as functional phagocytes can remove the GM effectively from the blood.

In a similar way, the use of mould active antifungal agents negatively affects the detection of GM in neutropenic patients which compromises the usefulness of GM screening in high-risk patients.

Interestingly, BDG often remains high following a fungal infection (e.g. candidaemia) even after several weeks which means it cannot be reliably used to monitor the success of anti-fungal treatment.

Ensuring samples are appropriate and timely

Another important part of fungal diagnostics is to ensure that patient samples are taken from the appropriate site and reach the laboratory in a timely manner.

Tests such as BDG or GM and Aspergillus PCR can be performed within a few hours of reaching the laboratory but the results are of little value if the samples take days in transit.

Other factors

Other factors that affect basic fungal diagnostics (culture & microscopy) are the quality of the sample, the transport and processing of these in the laboratory (as seen in the image below).

If a tissue biopsy of a suspected fungal lesion is macerated in the laboratory then some fungi, such as mucoracious moulds, get damaged and are unable to grow very well.

stage 1 is the selection of appropriate specimen (factors involved are clinical presentation, radiographic imaging, site of infection, most likely fungal pathogens). Stage 2 is specimen collection (factors involved are aseptic condition or after cleaning the collection site and sufficient amount). stage 3 specimen transport (factors involved are rapid transport in correct medium and temperature). stage 4 Clinical information (factors include guiding the processing and interpretation and biosafety) Specimen collection and transport

If you require a screen-reader compatible version of the above image, the information is available as a PDF.

It is also important to understand that failing to grow a fungus from culture does not rule out the diagnosis.

Failed diagnostics tests

There are a number of reasons for such failure including the wrong area of tissue has been biopsied, the tissue has been macerated destroying fungal elements, wrong culture temperature has been applied (some fungi only grow at low or high temperatures) or the length of culture period has been too short (some fungi take weeks to grow).

All in all, diagnostic mycology requires highly skilled expertise and it would be advisable to always discuss suspected fungal cases with a medical mycologist where possible.

If you’d like to learn more about fungal diagnostics, check out the full online course from BSAC, below.

© BSAC
This article is from the free online

Fungal Diagnostics in Critically Ill Patients

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now